Want to join the conversation?
$AMGN said the safety profile of erenumab was similar to placebo across both treatment arms. There was no adverse event reported in greater than 5% of patients treated with erenumab. The most common adverse events were injection site pain, upper respiratory tract infection and nausea.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!